LADARRYL BANKS: Open Payments
NPI 1922888114 · ADAMSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,695 in 130 payments from 20 companies in 2025. Trend: 2023 $15 · 2024 $1,207 · 2025 $2,695
Food & beverage: $2,695
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $469 |
| Novo Nordisk Inc | 15 | $293 |
| Abbott Laboratories | 2 | $267 |
| Sumitomo Pharma America, Inc. | 11 | $252 |
| GlaxoSmithKline, LLC. | 10 | $202 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $167 |
| Paratek Pharmaceuticals, Inc. | 15 | $160 |
| Corcept Therapeutics | 7 | $155 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $135 |
| Dexcom, Inc. | 7 | $129 |
Products named: FREESTYLE LIBRE 3, GEMTESA, FARXIGA, TRELEGY ELLIPTA, Ozempic, Kerendia, Korlym, JARDIANCE.
Industry payments across AL — which companies pay providers there.
